Atlantis Formulation Pvt Ltd

Gwarighat, Jabalpur, Madhya Pradesh

Atlantis formulations pvt. Ltd. Is a growing pcd pharma company in india, committed to increase access to high-quality healthcare by developing, producing and marketing affordable drugs in domestic as well as international markets. We have a team of outstanding professionals whose expertise in their domains contributes significantly to our success. The leadership team maximizes value for our customers, through good corporate governance that rests on the foundation of trust and transparency. Professional manpower, various product range, & strict quality control are the strengths of atlantis formulations pvt. Ltd. We have the capability to deliver quality product with established timelines without compromising the quality.
The company has extended operations by building further on already existing set-up by investing in new premises to include modern state of the art amenities. We have our corporate office at jabalpur. The promoters of the company are having a towering experience in pharmaceutical business for more than 40 years. We are continually reviewing and improving our efforts to lessen our impact on the environment, nurture a workplace of diversity and inclusion, conduct responsible business practices, and uphold the highest ethical standards in everything to sales and marketing, and we are building partnerships in communities throughout the world to strengthen health systems, increase access to our medicines and find sustainable solutions to the health challenges of today and tomorrow.
As a result of in-house research and development initiatives product basket includes: branded formulations covering more than 550 therapeutic formulations we produce a complementary portfolio of specialty ethical products targeting a wide spectrum of chronic and acute treatments. Our production capabilities span, difficult-to-make technology intensive products, over-the counter (otc), anti retroviral (arvs) and intermediates to local treatment needs while continually improving our global product offering. The therapeutic segments covered by our portfolio of over 550 high quality molecules include psychiatry, anti-infective, neurology, cardiology, orthopedic, dialectology, gastroenterology, nephrology, urology, dermatology, gynecology, respiratory, and nutritionals.